Bo Zhai | Healthcare Data Analysis | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Bo Zhai | Healthcare Data Analysis | Best Researcher Award

The Fourth Hospital of Harbin Medical University, China

Author Profile

Scopus

Early Academic Pursuits 📚

Dr. Bo Zhai, a highly respected Chief Physician and Associate Professor at The Fourth Hospital of Harbin Medical University, began his academic journey with a focus on hepatology and cell biology. After earning his MD, Dr. Zhai pursued advanced training as a Postdoctoral Fellow and later became a Fellow of the American College of Surgeons (FACS). His early academic work laid the foundation for his ongoing contributions to liver cancer research, particularly in the realm of hepatocellular carcinoma (HCC).

Professional Endeavors 🏥

Dr. Zhai has had a distinguished professional career, having served as a visiting scholar at the Liver Research Center of Brown University in the USA, sponsored by the National Foreign Experts Bureau. His work on liver cancer has been pivotal in understanding the complexities of HCC, a disease known for its resistance to conventional therapies like sorafenib. His international experience has broadened his research scope and enriched his academic and clinical expertise.

Contributions and Research Focus 🧬

Dr. Zhai’s primary research focus is on hepatocellular carcinoma (HCC), particularly how ASPH (Aspartate β-hydroxylase) influences cell death and contributes to chemoresistance in HCC. He has discovered that high levels of ASPH in HCC enhance proliferation, migration, and invasion, and also predict worse clinical outcomes for patients undergoing sorafenib treatment. His groundbreaking work suggests that targeting ASPH could break new ground in HCC therapy, overcoming the challenges posed by drug resistance.

Impact and Influence 🌍

Dr. Zhai’s research has had a significant impact on the field of liver cancer research, especially in understanding mechanisms of resistance to conventional cancer therapies. His studies on ASPH in HCC have opened new avenues for therapeutic interventions, providing insights into the role of autophagy, ferroptosis, and cell survival pathways in cancer progression. His work has been published in prestigious journals, including Cancer Letters, and is cited widely, underlining his contribution to the scientific community.

Academic Citations 📈

With an impressive citation index of 17.7, Dr. Zhai’s work is highly regarded in the academic community. His research publications, particularly those related to ASPH and HCC, have made substantial contributions to the understanding of liver cancer biology. His studies have provided valuable insights into the molecular mechanisms behind HCC’s resistance to chemotherapy, paving the way for new therapeutic strategies.

Technical Skills 🔬

Dr. Zhai has a wide range of technical skills, including expertise in molecular biology, cancer cell biology, and animal model studies. His proficiency in studying autophagy, ferroptosis, and tumor metastasis has made him a leader in the field of liver cancer research. Additionally, his experience with gene silencing and knockout models has allowed him to explore new potential targets for cancer treatment.

Teaching Experience 🧑‍🏫

As an Associate Professor, Dr. Zhai has contributed significantly to the education and mentoring of graduate and medical students. He has supervised numerous Master’s students and postdoctoral fellows, passing on his expertise in liver cancer research. His teaching extends beyond the classroom, as he is also involved in sharing his knowledge and findings through academic conferences and seminars.

Legacy and Future Contributions 🌱

Dr. Zhai’s legacy in liver cancer research is already well-established, with his groundbreaking work on ASPH setting the stage for future therapeutic developments. As he continues to pursue innovative approaches in HCC treatment, his research promises to lead to better clinical outcomes for patients battling liver cancer. His future contributions to the field will likely focus on developing targeted therapies that can overcome chemoresistance and improve patient survival rates.

Top Noted Publications 📖

ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma
    • Authors: Jingtao Li, Guocai Zhong, Fengli Hu, Qiushi Lin, Xiaoqun Dong, Bo Zhai
    • Journal: Cancer Letters
    • Year: 2024
Mechanisms of vascular co-option as a potential therapeutic target in hepatocellular carcinoma
    • Authors: Ming-Hao Qi, Jing-Tao Li, Bo Zhai
    • Journal: World Chinese Journal of Digestology
    • Year: 2024
Aspartate-β-hydroxylase as a promising prognostic and therapeutic biomarker for HBV-positive hepatocellular carcinoma
    • Authors: Jingtao Li, Zongwen Wang, Xiaohang Ren, WenYu Liu, Shicong Zeng, Bo Zhai
    • Journal: Research Square
    • Year: 2023
Is hepatic resection always a better choice than radiofrequency ablation for solitary hepatocellular carcinoma regardless of age and tumor size?
    • Authors: Shicong Zeng, Yao Zhang, Zongwen Wang, Qiankun Zhu, Yan Yan, Bo Zhai
    • Journal: Biomolecules & Biomedicine
    • Year: 2023
Identification of risk and prognostic factors for intrahepatic vascular invasion in patients with hepatocellular carcinoma: a population-based study
    • Authors: Shicong Zeng, Zongwen Wang, Qiankun Zhu, Fengli Hu, Lishan Xu, Bo Zhai
    • Journal: Translational Cancer Research
    • Year: 2022

Hao Gao | Healthcare Data Analysis | Best Researcher Award

Posted on by ScienceFather

Prof. Hao Gao | Healthcare Data Analysis | Best Researcher Award

Jinan University, China

Author Profiles

orcid

Scopus

Research Gate

👨‍🎓 Early Academic Pursuits

Prof. Hao Gao began his academic journey with a strong foundation in natural medicine chemistry. He received his PhD from Shenyang Pharmaceutical University in 2005, focusing on the chemistry of natural medicines. This early academic work set the stage for his future contributions to the field of Traditional Chinese Medicine (TCM). After completing his doctorate, he further honed his expertise through postdoctoral training at Tsinghua University (2006-2008), a renowned institution that significantly influenced his approach to scientific research and innovation.

💼 Professional Endeavors and Leadership

Prof. Gao’s professional trajectory has been marked by leadership roles that have shaped his career and the direction of his research. In 2008, he joined the Institute of Traditional Chinese Medicine & Natural Products at Jinan University as a faculty member. Since 2013, he has been a professor at the university and, in 2016, assumed the position of Head of the Institute of Traditional Chinese Medicine & Natural Products. In 2020, he expanded his administrative responsibilities by taking on the role of Director of the Science and Technology Department at Jinan University. Prof. Gao’s leadership has been pivotal in fostering multidisciplinary collaborations and advancing research initiatives in natural medicine chemistry.

🔬 Contributions and Research Focus

Prof. Gao’s research is primarily centered on natural medicine chemistry, with a particular focus on the active compounds and technological advancements related to Traditional Chinese Medicine (TCM). His work is dedicated to exploring under-researched medicinal materials like Lycium barbarum, Angelica sinensis, and Ophiocordyceps sinensis, which are central to TCM practices. Prof. Gao has made significant strides in identifying bioactive substances and developing novel drugs derived from TCM. Notably, his research has led to the discovery of four classes of lead compounds for anti-dementia drugs, all characterized by independent intellectual property rights.

🌍 Impact and Influence

Prof. Gao’s impact extends beyond academia, with substantial contributions to the modernization of TCM and drug development. His collaborations with international experts, such as Professor Ikuro Abe from the University of Tokyo, have facilitated the establishment of the International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, a joint initiative between China’s Ministry of Education and Jinan University. This partnership exemplifies Prof. Gao’s influence on global TCM research and highlights his role in pushing the boundaries of natural product-based drug development.

📚 Academic Citations and Recognition

Prof. Gao’s research has gained widespread recognition, reflected in his 4100 citations across various SCI journals. His work has significantly contributed to the advancement of natural medicine chemistry and TCM, making him a highly influential figure in the field. His numerous publications, with 195 journal articles and one book published, continue to shape research in TCM and pharmacology. Moreover, his leadership as an editor for the China Section of the Journal of Natural Medicines and as an editorial board member for Acta Pharmaceutica Sinica B highlights his prominence in the academic community.

🛠️ Technical Skills and Innovations

Prof. Gao’s technical expertise spans various critical areas, including the extraction, isolation, and characterization of bioactive compounds from TCM. His innovations in pharmacodynamic constituents of TCM have contributed to the discovery of novel drug candidates, some of which are in the process of patenting. With over 71 patents published or pending, Prof. Gao stands at the forefront of translating TCM practices into scientifically validated therapeutic solutions. His lab continues to focus on critical technologies that aim to enhance the efficacy and safety of TCM-derived medicines.

👩‍🏫 Teaching Experience

In addition to his research, Prof. Gao has been an integral part of the academic community at Jinan University, mentoring and guiding students in the fields of pharmacology and natural medicine chemistry. His teaching philosophy integrates cutting-edge research with practical applications in TCM, ensuring that his students are well-equipped to pursue careers in both academia and industry. As a mentor, Prof. Gao has inspired numerous graduate students and postdoctoral researchers, many of whom have gone on to make their own contributions to TCM and drug development.

🌱 Legacy and Future Contributions

Prof. Gao’s legacy is built on his pioneering work in natural medicine chemistry and the modernization of Traditional Chinese Medicine. His research continues to influence the field, with ongoing projects that promise to uncover more bioactive compounds and therapeutic agents. As his career progresses, Prof. Gao remains committed to advancing TCM through innovation and interdisciplinary collaboration. His future work will likely expand the global recognition of TCM-based drugs, pushing the boundaries of natural product drug discovery and pharmacology for the betterment of human health.

🌟 Professional Memberships and Editorial Roles

Prof. Gao is an active member of the China Association of Chinese Medicine, where he serves as Vice Chairperson of the Youth Work Committee. His role in professional societies and editorial boards, including his editorial positions in high-impact journals, underscores his authority in the fields of natural products and biosynthesis. His leadership extends to guiding the next generation of researchers and practitioners in these fields.

📖 Top Noted Publications 

Functional and structural dissection of glycosyltransferases underlying the glycodiversity of wolfberry-derived bioactive ingredients lycibarbarspermidines
    • Authors: Li, S.-Y., Wang, G.-Q., Long, L., Abe, I., Gao, H.
    • Journal: Nature Communications
    • Year: 2024
Identification of three novel P450 enzymes involved in the oxidative modification of a newly discovered fusicoccane diterpene
    • Authors: Dong, L., Liu, J.-Y., Wang, G.-Q., Hu, D., Gao, H.
    • Journal: Bioorganic Chemistry
    • Year: 2024
Targeted Discovery of a Natural ortho-Quinone Methide Precursor and Green Generation of Its Oligomers
    • Authors: Wang, X.-X., Deng, B.-Q., Ouyang, Z.-Q., Yao, X.-S., Gao, H.
    • Journal: Journal of Natural Products
    • Year: 2024
A Functional Switch Between Asperfumene and Fusicoccadiene Synthase and Entrance to Asperfumene Biosynthesis through a Vicinal Deprotonation-Reprotonation Process
    • Authors: Liu, J.-Y., Lin, F.-L., Taizoumbe, K.A., Gao, H., Dickschat, J.S.
    • Journal: Angewandte Chemie – International Edition
    • Year: 2024
Mechanistic characterisation of a fungal fusicoccane-type diterpene synthase involved in the biosynthesis of talaro-7,13-diene
    • Authors: Lin, F.-L., Taizoumbe, K.A., Wang, Y.-X., Gao, H., Dickschat, J.S.
    • Journal: Organic and Biomolecular Chemistry
    • Year: 2024

Tahar Kernif | Healthcare Data Analysis | Excellence in Research

Posted on by ScienceFather

Dr. Tahar Kernif | Healthcare Data Analysis | Excellence in Research

Institut Pasteur Algérie, Algeria

Author Profile

🎓 Early Academic Pursuits

Dr. Tahar Kernif’s academic journey began in 2004 when he completed his Doctorate in Veterinary Science at the École Nationale Vétérinaire d’Alger, where he conducted a comparative study on treatments for canine Leishmaniasis. This research laid the foundation for his future work in veterinary parasitology. Dr. Kernif then pursued a Magistère in Parasitology at the same institution, focusing on zoonotic diseases and vectors, which further honed his expertise in vector-borne infections. These early academic achievements earned him distinction and sparked his lifelong commitment to studying infectious diseases.

🧑‍🔬 Professional Endeavors

Since 2013, Dr. Kernif has been a Maître de Recherche at the Institut Pasteur d’Alger, where he works on molecular techniques to study parasitic diseases in veterinary science. His research focuses on Protozoa, Helminths, and the molecular ecology of arthropod vectors. He has played an integral role in shaping the institute’s research activities on infectious diseases and environmental health, contributing to key initiatives in the field of veterinary parasitology. Dr. Kernif’s professional work is also marked by collaborations with international research institutions such as CIRAD and IRD, where he has worked on studying arthropod microbiota through meta-proteomics.

🔬 Contributions and Research Focus

Dr. Kernif’s primary research interests lie in Infectious Diseases and Health and Environment, specifically focusing on multi-omics approaches to understanding pathogen behavior. His work spans genomics, metagenomics, and proteomics, applying these techniques to study diseases like leishmaniasis and tick-borne infections. His research includes phylogenetic analysis and bioinformatic modeling, which have contributed significantly to the molecular understanding of parasite-host interactions, providing insights into disease transmission and control strategies.

🌍 Impact and Influence

Dr. Kernif’s contributions extend beyond research, as he is actively involved in national health policy and scientific review boards. He served as associate editor for New Microbes and New Infections and has been a scientific examiner for the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). His work has shaped policies related to biodiversity and environmental health, especially in Algeria, where he is part of the National Expert Working Group for the Libreville Declaration on Health and Environment. His influence on public health and policy is a testament to his broad impact in both scientific and governmental circles.

📚 Academic Cites

Dr. Kernif has authored 35 international publications and contributed to two book chapters, demonstrating his prominent role in infectious disease research. His studies are frequently cited in scientific journals, reflecting his influence in veterinary parasitology and zoonotic diseases. His work in molecular epidemiology and vector-borne pathogens has made a lasting impact on the field and continues to guide contemporary research.

🛠️ Technical Skills

Dr. Kernif is highly proficient in a range of advanced techniques critical to research in parasitology and microbiology. His expertise spans capillary sequencing, next-generation sequencing (NGS), and PCR/qPCR, which are essential for molecular surveillance and unraveling genetic information. He is also skilled in MALDI-TOF Mass Spectrometry, currently in progress, allowing for detailed molecular analysis of pathogens. Additionally, Dr. Kernif utilizes bioinformatics to analyze complex datasets, helping to interpret vast amounts of biological data. His proficiency in meta-proteomics is instrumental in studying the microbiota of arthropods, providing insights into disease mechanisms and transmission. These tools equip Dr. Kernif with the ability to conduct precise and impactful research, advancing our understanding of infectious diseases.

👩‍🏫 Teaching Experience

Throughout his career, Dr. Kernif has shared his expertise through academic mentorship and scientific training. As a researcher at the Institut Pasteur d’Alger, he supervises graduate students and engages in international collaborations to promote knowledge exchange. His teaching and mentorship in the field of veterinary parasitology and infectious diseases continue to shape the next generation of scientists.

🌱 Legacy and Future Contributions

Dr. Kernif’s legacy is marked by his scientific publications, international collaborations, and his influence in shaping research policy in infectious diseases. Moving forward, his research is poised to address emerging health threats, particularly those arising from vector-borne diseases. His continued contributions to global health initiatives and his work on disease surveillance are expected to leave a lasting mark on the fields of veterinary entomology and infectious disease control.

 

📖 Top Noted Publications

Update on tick-borne rickettsioses around the world: a geographic approach
    • Authors: P Parola, CD Paddock, C Socolovschi, MB Labruna, O Medianikov, …
    • Journal: Clinical Microbiology Reviews
    • Year: 2013
Borrelia, Rickettsia, and Ehrlichia species in bat ticks, France, 2010
    • Authors: C Socolovschi, T Kernif, D Raoult, P Parola
    • Journal: Emerging Infectious Diseases
    • Year: 2012
Matrix-assisted laser desorption ionization–time of flight mass spectrometry for rapid identification of tick vectors
    • Authors: A Yssouf, C Flaudrops, R Drali, T Kernif, C Socolovschi, JM Berenger, …
    • Journal: Journal of Clinical Microbiology
    • Year: 2013
Identification of flea species using MALDI-TOF/MS
    • Authors: A Yssouf, C Socolovschi, H Leulmi, T Kernif, I Bitam, G Audoly, L Almeras, …
    • Journal: Comparative Immunology, Microbiology and Infectious Diseases
    • Year: 2014
Rickettsiae of spotted fever group, Borrelia valaisiana, and Coxiella burnetii in ticks on passerine birds and mammals from the Camargue in the south of France
    • Authors: C Socolovschi, P Reynaud, T Kernif, D Raoult, P Parola
    • Journal: Ticks and Tick-Borne Diseases
    • Year: 2012

Kirsten Tolstrup | medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Kirsten Tolstrup | Medicine | Best Researcher Award

Doctorate at UCSF School of Medicine, United States

👨‍🎓Professional Profile

👩‍⚕️ Summary

Dr. Kirsten Tolstrup is a distinguished cardiologist with extensive experience in cardiovascular disease, adult comprehensive echocardiography, and women’s heart health. With certifications in Internal Medicine, Cardiovascular Disease, and Echocardiography, she has held leadership roles at prominent institutions such as UCSF, Cedars-Sinai, and UNM. She is currently the Associate Chief of Cardiology at UCSF and serves as the Interim Medical Director of the HVC in the Division of Cardiology.

🎓 Education

Dr. Tolstrup completed her MD at the University of Copenhagen, Denmark, in 1993. She holds a BS from the University of Copenhagen, obtained in 1988. She pursued her Internal Medicine Residency at USC-LAC Medical Center in Los Angeles (1995-1998) and completed a Cardiovascular Medicine Fellowship at the UNM Health Sciences Center in Albuquerque (1998-2001).

💼 Professional Experience

Throughout her career, Dr. Tolstrup has held key roles, including Associate Chief of Cardiology at UCSF (2020-present), Medical Director of the Heart Station and Echo Laboratory at UNM (2012-2016), and Director of the Cardiac Non-invasive Stress Laboratory at Cedars-Sinai (2009-2012). She has also served as an Associate Clinical Professor at UCLA and Professor of Medicine at UCSF.

📚 Academic Citations

Dr. Tolstrup has made significant academic contributions, authoring chapters in notable medical texts such as Current Diagnosis and Treatment in Cardiology and The Ultimate Echo Guide. She has contributed to clinical guidelines on the use of echocardiography for cardiac embolism and heart disease in pregnancy.

🛠️ Technical Skills

She is highly skilled in adult comprehensive echocardiography and non-invasive cardiovascular imaging, with expertise in cardiac diagnostics and advanced echocardiographic techniques. Her technical proficiency also extends to cardiovascular risk assessment and imaging.

👩‍🏫 Teaching Experience

Dr. Tolstrup has shared her knowledge through teaching roles, including as a Teaching Associate at UCLA and Professor of Medicine at UCSF. She also served as an Instructor/Master at Dynamic Taekwondo Academy and remains actively involved in mentoring and instructing future cardiologists.

🔬 Research Interests

Her research interests focus on cardiovascular imaging, particularly in the areas of women’s heart health, aortic diseases, and heart failure. Dr. Tolstrup is dedicated to advancing the clinical applications of echocardiography and understanding cardiovascular risks across diverse populations.

📖Top Noted Publications

Very low prevalence and incidence of atrial fibrillation among Bolivian forager-farmers

Authors: Rowan, C.J., Eskander, M.A., Seabright, E., Kaplan, H.S., Gurven, M.D.
Journal: Annals of Global Health
Year: 2021

Update on Bicuspid Aortic Valve Syndrome: Patient Selection and Therapies in 2020

Authors: Anderson, D., Grober, A., Mahadevan, V., Tolstrup, K.
Journal: Current Treatment Options in Cardiovascular Medicine
Year: 2020

The clinical application of the ratio of transmitral early filling velocity to early diastolic strain rate: a systematic review and meta-analysis

Authors: Lassen, M.C.H., Olsen, F.J., Skaarup, K.G., Gislason, G., Biering-Sørensen, T.
Journal: Journal of Echocardiography
Year: 2020

 A Case-Based Discussion on the Management of Cryptogenic Stroke and Patent Foramen Ovale in the Patient With a Hypercoagulable Disorder

Authors: Gerstein, N.S., Clegg, S.D., Levin, D.B., Yoshida, Y., Homma, S.
Journal: Journal of Cardiothoracic and Vascular Anesthesia
Year: 2019

Ratio of transmitral early filling velocity to early diastolic strain rate predicts long-term risk of cardiovascular morbidity and mortality in the general population

Authors: Lassen, M.C.Hø., Biering-Sørensen, S.R., Olsen, F.J., Jensen, J.S., Biering-Sørensen, T.
Journal: European Heart Journal
Year: 2019

Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism

Authors: Saric, M., Armour, A.C., Arnaout, M.S., Michelena, H.I., Tolstrup, K.
Journal: Journal of the American Society of Echocardiography
Year: 2016

Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Posted on by ScienceFather

Dr. Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Dr. Laurence Vaughan at Becton Dickinson and Company, United States

👨‍🎓 Professional Profile

🎓 Early Academic Pursuits

Dr. Laurence Vaughan began his academic journey at the University of Dublin, Trinity College, where he earned a BA (Honors) in Natural Sciences (Genetics) in 1986, followed by a Ph.D. in Molecular Microbiology in 1991. His doctoral research focused on the aroA gene of Aeromonas salmonicida, contributing to foundational knowledge in microbiology and vaccine development.

🏢 Professional Endeavors

Dr. Vaughan’s career spans over three decades in the biotechnology and molecular diagnostics sectors. Currently, he serves as the Director of Scientific Affairs at Becton Dickinson and Company, focusing on integrated diagnostic solutions for women’s health, particularly cervical cancer screening. His past roles include R&D leadership at QIAGEN and Corning Incorporated, where he made significant advancements in molecular assay development and product support.

🌟 Contributions and Research Focus

Dr. Vaughan has led teams in developing groundbreaking products such as the BD Onclarity cervical cancer screening test, which received CE Mark approval in 2014 and US-PMA approval in 2018. He has authored content for international conferences and peer-reviewed publications, emphasizing his commitment to advancing scientific knowledge and product innovation in the diagnostics field.

🌍 Impact and Influence

His work has not only shaped diagnostic guidelines but has also influenced industry standards, as seen with the American Society for Colposcopy and Cervical Pathology (ASCCP) management guidelines launched in 2020. Dr. Vaughan’s expertise is recognized internationally, making him a sought-after speaker at various conferences.

📚 Academic Cites

Dr. Vaughan has made notable contributions to the field of vaccinology, evidenced by multiple patents and publications. His editorial experience as the Editor-in-Chief of “Diseases of Aquatic Organisms” from 1995 to 1999 further underscores his leadership in academic discourse.

🔧 Technical Skills

Dr. Vaughan possesses extensive technical skills in molecular biology, microbiology, and genetics. His proficiency in managing clinical trials, particularly in the R&D lead for Onclarity HPV clinical trials, highlights his ability to oversee complex scientific projects.

👩‍🏫 Teaching Experience

Throughout his career, Dr. Vaughan has demonstrated a passion for education and mentorship. He has developed and delivered training for global customers and internal teams, showcasing his strong communication and interpersonal skills.

🏅 Legacy and Future Contributions

Dr. Vaughan’s legacy includes a robust portfolio of innovations and leadership in the biotech field. His achievements, such as the Becton Dickinson Wesley J. Howe Award for Technological Innovation in 2013, reflect his dedication to advancing science and technology. Looking ahead, he aims to continue contributing to the development of effective diagnostic solutions and vaccines, focusing on emerging health challenges.

 

📖 Top Noted Publications

Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening

Authors: Vaughan, L., Gary, D., Shah, M., Galbraith, L., Parvu, V.
Journal: Gynecologic Oncology Reports
Year: 2024

Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial

Authors: Stoler, M.H., Parvu, V., Yanson, K., Andrews, J., Vaughan, L.
Journal: Gynecologic Oncology
Year: 2023

Validation of a New High-Throughput BD COR System Using the BD CTGCTV2 Assay

Authors: Taylor, S., Rucki, A., Lockamy, E., Vaughan, L., Greene, W.
Journal: Journal of Molecular Diagnostics
Year: 2022

Evaluation of the Onclarity HPV assay on the high-throughput COR system

Authors: Taylor, S.N., Eckert, K., Rucki, A.A., Vaughan, L.M., Greene, W.H.
Journal: Expert Review of Molecular Diagnostics
Year: 2021

Cotesting in cervical cancer screening

Authors: Malinowski, D.P., Broache, M., Vaughan, L., Andrews, J., Gary, D.
Journal: American Journal of Clinical Pathology
Year: 2021

Analytical and clinical sample performance characteristics of the onclarity assay for the detection of human papillomavirus

Authors: Young, S., Vaughan, L., Yanson, K., Cooper, C.K., van der Pol, B.
Journal: Journal of Clinical Microbiology
Year: 2021

Gang Wang | Biosensing and Bioimaging | Best Researcher Award

Posted on by ScienceFather

Dr. Gang Wang | Biosensing and Bioimaging | Best Researcher Award

Doctorate at Guizhou Normal University, China

👨‍🎓 Profiles

Academic Background 🎓

Dr. Gang Wang holds a PhD in Solid Mechanics from Peking University (2017), a Master’s degree in Integrated Circuit Engineering from Tsinghua University (2013), and a Bachelor’s degree in Engineering Physics from Tsinghua University (2008).

Education 📚

  • PhD: Solid Mechanics, Peking University (2017)
  • Master’s: Integrated Circuit Engineering, Tsinghua University (2013)
  • Bachelor’s: Engineering Physics, Tsinghua University (2008)

Professional Experience 💼

Gang Wang is currently the Deputy Dean at Guizhou Normal University (2021-present), where he also serves as a Lecturer and Master Supervisor. He was seconded to the Department of Technology Talent at the Department of Science and Technology of Guizhou Province from April 2022 to May 2023.

Research Interest 🔬

Dr. Wang’s research focuses on microrobots and integrated circuits. His work includes developing innovative surface microstructures and multifunctional hydrogels to enhance microrobot motion efficiency and advance biomedical applications.

 Professional Memberships🔗

Gang is the Director of the Guizhou Integrated Circuits Society, contributing to the advancement of integrated circuits research in his region.

📖  Top Noted Publications
Multifunctional Hydrogel with 3D Printability, Fluorescence, Biodegradability, and Biocompatibility for Biomedical Microrobots
    • Author: Gang Wang, Sisi Wang, Tao Hu, Famin Shi
    • Journal: Molecules
    • Year: 2024
Understanding the Intrinsic Mechanism of High-Performance Electrocatalytic Nitrogen Fixation by Heterogenization of Homonuclear Dual-Atom Catalysts
    • Author: Yuefei Zhang, Yu Yang, Yu Zhang, Xuefei Liu, Wenjun Xiao, Degui Wang, Gang Wang, Zhen Wang, Jinshun Bi, Jincheng Liu et al.
    • Journal: Energy & Environmental Materials
    • Year: 2024
Enhancing Swimming Performance of Magnetic Helical Microswimmers by Surface Microstructure
    • Author: Gang Wang, Sisi Wang, Famin Shi, Xuefei Liu, Degui Wang, Aierken Abuduwayiti, Zhen Wang, Mingqiang Liu, Yan Wu, Jinshun Bi
    • Journal: Langmuir
    • Year: 2024
The Rational Co-Doping Strategy of Transition Metal and Non-Metal Atoms on g-CN for Highly Efficient Hydrogen Evolution by DFT and Machine Learning
    • Author: Yu Yang, Xin Zhao, Tianyun Liu, Yuefei Zhang, Yuanjun Hu, Xuefei Liu, Gang Wang, Degui Wang, Jinshun Bi, Zijiang Luo et al.
    • Journal: International Journal of Hydrogen Energy
    • Year: 2024
Coordination Engineering on Novel 2D Pentagonal NiN₂ for Bifunctional Oxygen Electrocatalysts
    • Author: Yuanjun Hu, Xin Zhao, Yu Yang, Wenjun Xiao, Xun Zhou, Degui Wang, Gang Wang, Jinshun Bi, Zijiang Luo, Xuefei Liu
    • Journal: Applied Surface Science
    • Year: 2023
Theoretical Calculation of Hydrogen Evolution Reaction in Two-Dimensional As₂X₃(X=S, Se, Te) Doped with Transition Metal Atoms
    • Author: Xin Zhao, Yu Yang, Yuanjun Hu, Gang Wang, Degui Wang, Yanfeng Wei, Shuxing Zhou, Jinshun Bi, Wenjun Xiao, Xuefei Liu
    • Journal: Applied Surface Science
    • Year: 2023

Ma-am Joy Tumulak – Healthcare Data Analysis – Best Researcher Award 

Posted on by ScienceFather

Dr. Ma-am Joy Tumulak - Healthcare Data Analysis - Best Researcher Award 

University of the Philippines Manila - Philippines

Author Profile

Early Academic Pursuits

Dr. Joy R. Tumulak embarked on her academic journey with a solid foundation in psychology, graduating cum laude from the University of the Philippines, Diliman with a Bachelor of Science degree. Her pursuit of understanding human behavior and cognition laid the groundwork for her future endeavors in the medical field. She continued her academic pursuit at the University of the Philippines, Ermita, Manila, where she earned her Doctor of Medicine degree, showcasing her commitment to the medical profession from an early stage. Throughout her academic journey, she demonstrated excellence, earning recognition as an Outstanding Intern in Rehabilitation Medicine during her medical training.

Professional Endeavors

Dr. Tumulak's professional journey has been characterized by a passion for genetics and genetic counseling. She began her career as a Medical Officer at Taytay District Hospital, Palawan, where she gained valuable clinical experience in managing outpatient and emergency care. Transitioning into the realm of genetics, she served as a Research Associate for the Subphenotyping and Genetics of Oral Facial Cleft Families in the Philippines Study, collaborating with the University of Pittsburgh. Her role involved not only research coordination but also the adaptation and development of study protocols, showcasing her versatility in both clinical and research settings.

Dr. Tumulak's commitment to advancing genetic research and counseling led her to roles at the Institute of Human Genetics, National Institutes of Health, University of the Philippines Manila. As a University Researcher and later as a Research Assistant Professor, she played a pivotal role in conceptualizing and initiating research projects related to genetics and genetic counseling. Her expertise in manuscript writing and protocol development contributed significantly to the publication of numerous research papers in international and local journals.

Contributions and Research Focus

Dr. Tumulak's research focus encompasses a broad spectrum of genetic disorders, ranging from metabolic diseases like Maple Syrup Urine Disease to congenital heart defects and rare genetic syndromes. Her studies delve not only into the clinical aspects of these conditions but also into the psychosocial implications for patients and their families. Through her research, she has shed light on the coping strategies of Filipino mothers of children with congenital heart disease and the psychosocial issues faced by parents of children with Maple Syrup Urine Disease.

In addition to her research endeavors, Dr. Tumulak has been actively involved in genetic counseling initiatives, advocating for the integration of genetic counseling services into clinical practice. Her contributions extend beyond academia, as evidenced by her involvement in various professional organizations such as the Philippine Society of Genetic Counselors and the Professional Society of Genetic Counselors in Asia.

Accolades and Recognition

Dr. Tumulak's contributions to the field of genetics and genetic counseling have been recognized through grants, awards, and invitations to present at prestigious conferences and symposiums. She has received research dissemination grants from UP Manila and publication awards from the University of the Philippines Manila in acknowledgment of her impactful research endeavors. Her excellence has been further acknowledged through awards such as the Outstanding Intern Award and cum laude recognition during her academic pursuits.

Impact and Influence

Dr. Tumulak's work has made a significant impact on the field of genetic counseling, particularly in the Philippines and the broader Asian region. Her research publications, presentations, and involvement in professional organizations have contributed to the advancement of genetic knowledge and the development of genetic counseling services. Through her dedication and leadership, she has inspired future generations of genetic counselors and researchers to continue pushing the boundaries of knowledge in the field.

Legacy and Future Contributions

As Dr. Tumulak continues her professional journey, her legacy lies in her commitment to excellence, innovation, and advocacy for genetic health. Her future contributions are poised to further expand the scope of genetic counseling and research, addressing the evolving needs of patients and families facing genetic conditions. With her leadership and expertise, she will undoubtedly leave a lasting impact on the field, shaping the future of genetics and genetic counseling in the Philippines and beyond.

Citations

A total of 43 citations for his publications, demonstrating the impact and recognition of her research within the academic community.

  • Citations    43
  • h-index       2

Notable Publication